Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
China | Publication | September 2023
On 1 January 2020, the China Securities Regulatory Commission (the CSRC) officially removed the foreign ownership restrictions on foreign investment into futures companies in China completely (please see our previous publication here).
Market reaction to this liberalisation has been positive. In June 2020, JPMorgan increased its equity holding in its futures joint venture from 49% to 100%, which marked the establishment of the first wholly foreign-owned futures company in China. In May 2023, another foreign investment bank, Morgan Stanley, also received approval from CSRC to set up a futures subsidiary, becoming the second wholly foreign-owned futures company in China.
In the last three years, despite the pandemic, the Chinese government has not slowed down its pace in further liberalising the futures market as well as refining the relevant laws and regulations.
The highly anticipated PRC Futures and Derivatives Law (the New Futures Law), being the first comprehensive legal framework for the futures and derivatives markets in China, was officially promulgated, and came into effect, on August 1, 2022. Amongst various other highlights, the New Futures Law sets out a clear registration and approval regime in respect of cross-border futures activities, summarised as follows:
The New Futures Law heralds a positive signal that CSRC will re-open the application and approval for PRC futures brokers to conduct overseas futures brokerage business. However, it also suggests that overseas futures brokers should still be cautious in their activities in and relating to China as they would fall within the regulatory ambit of CSRC pursuant to the New Futures Law.
In addition, the New Futures Law also leaves ambiguities in a few areas, which CSRC may shed light on in subsequent implementation rules. For example, historically qualified state-owned entities (SOEs) are explicitly permitted to conduct futures trading at overseas market for hedging purpose only, and in practice, such SOEs may have engaged overseas futures brokers directly to conduct the underlying trading. From reading the New Futures Law, such business structure seems no longer acceptable – a qualified PRC futures broker must be engaged to intermediate such trades. It remains unclear whether such existing business structures may remain in their status quo or would need to be restructured pursuant to the New Futures Law.
Following the promulgation of the New Futures Law, CSRC has been actively progressing legislative updates with the aim of aligning with the new law and to facilitate its implementation. Those legislative updates cover a wide range of specific activities - stock option trading, position management, derivative trading, administrative rules on futures companies and individual practitioners.
Here is a summary of the various updates under the draft Amended Administrative Measures on Futures Companies (the Draft Measures) that may be of interest to foreign investors.
Expanded business scope of futures companies
As one of the key updates, the Draft Measures expand the permitted business activities that futures companies may conduct directly. Those permitted activities, as expressly outlined in the Draft Measures, include futures brokerage (both commodity futures and financial futures), overseas futures brokerage, futures trading consultancy, futures market making, futures margin financing, futures proprietary business, derivative trading, asset management and other businesses that CSRC may approve.
Futures brokerage can be conducted by futures companies upon establishment, whilst the other businesses are still subject to certain qualification requirements and separate approval by CSRC. Specifically, futures margin financing, futures proprietary business and overseas futures brokerage are subject to separate rules to be stipulated by CSRC.
It is common in practice that futures companies may have established special purpose subsidiaries to conduct the derivative trading business, asset management business and market making business. According to the Draft Measures and several ancillary draft notices issued by the China Futures Association (being a self-regulatory organization for the China futures industry), such businesses would need to be transferred back to the futures companies within a prescribed grace period (e.g. 36 to 48 months) after the Draft Measures come into effect
The Draft Measures, however, do not contain more detailed rules on the conduct of cross-border futures activities as addressed in the New Futures Law, such as the registration rules for overseas brokers to conduct overseas futures trading per engagement by onshore PRC brokers, as well as the regulatory requirements that overseas futures institutions shall meet in order to obtain CSRC approval to conduct futures marketing, promotion and solicitation activities in China. According to CSRC's official explanatory note, those subjects are pending further research and analysis by CSRC.
Requirements on shareholders/actual controllers
Like the current regime, the major shareholders of future companies (i.e. those with a shareholding greater than 5%) are subject to various qualification requirements relating to capital/asset size, source of funds, track record, status of credit and debts, etc. A controlling shareholder and the largest shareholder of a futures company are subject to additional requirements, such as having strong advantages in technical capabilities, management and service skills, staff training and/or marketing channels, and capital replenishment capability.
A look-through regulatory approach is still adopted by CSRC. Direct shareholders of futures companies are required to disclose their upper-level shareholding structure, i.e. information of actual controller/ultimate beneficiary, person acting-in-concert and related parties. The Draft Measures expressly provide that certain specific qualification requirements (e.g. net capital/net assets, track record) which apply to the direct shareholders should equally apply to the actual controllers, and this is what the current regime is silent on.
The Draft Measures also set out certain restrictions on the disposal of shares by the shareholders. The shareholders or actual controllers of futures companies are expressly prohibited from signing agreements or entering into arrangements involving a valuation adjustment mechanism, under which a share redemption or transfer of equity would be triggered as between a specific shareholder and the underlying futures company if and when the futures company fails to meet specific conditions . Futures companies are also required to report such arrangements to the local office of CSRC within five working days after being aware of the same.
On May 25, 2023, the Shanghai Futures Exchange held the 20th Shanghai Derivatives Market Forum. Mr. Xinghai Fang, vice chairman of CSRC, in his opening speech remarked that China would continue to expand the "width and depth" of the liberalisation of the Chinese futures market and will allow qualified foreign institutional investors to trade in a wider range of futures varieties.
According to Fang, up to 23 specific futures varieties are now available to offshore investors, as well as 39 commodity futures option varieties available to the Qualified Foreign Institutional Investors (QFIIs) and RMB Qualified Foreign Institutional Investors (RQFII).
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
While country risk cannot be avoided in cross-border transactions entirely, it can be effectively mitigated through careful transaction structuring and tailored contractual protections.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023